6 Best Peptides for Restless Leg Syndrome
Restless Leg Syndrome sits at the early frontier of peptide research. No peptide has been clinically validated or FDA-approved specifically for RLS, and the two compounds most often discussed in peptide communities, BPC-157 and Selank, have zero direct RLS trial data. What does exist is a genuinely important scientific lead: CGRP, a neuropeptide involved in pain signaling, has been found dysregulated in RLS patients in human studies, and compounds targeting that pathway have produced measurable symptom relief in small clinical trials. This guide covers six peptides people are researching and discussing for RLS, ordered by how prominently each appears in the science and in real-world use, not as a ranking of one compound over another. The honest picture is that this field is early, evidence is thin across the board, and for most people managing RLS today, non-peptide approaches remain the better-established path.
